Showing results (1-10 of 139) with videos related to
Sort By:
Pageof 14
Cancer Cell|December 15, 2021
Improving immunotherapy response through the use of designer bacteriaMatthew E Griffin, Howard C HangNeoplasia (New York, N.Y.)|July 11, 2022
Microbial mechanisms to improve immune checkpoint blockade responsivenessMatthew E Griffin, Howard C HangBiorxiv : the Preprint Server for Biology|February 7, 2023
N -arylpyrazole NOD2 agonists promote immune checkpoint inhibitor therapyMatthew E Griffin, Taku Tsukidate, Howard C HangACS Chemical Biology|May 12, 2023
N-Arylpyrazole NOD2 Agonists Promote Immune Checkpoint Inhibitor TherapyMatthew E Griffin, Taku Tsukidate, Howard C HangCell Chemical Biology|November 23, 2022
Peptidoglycan NlpC/P60 peptidases in bacterial physiology and host interactionsMatthew E Griffin, Steven Klupt, Juliel Espinosa, et al.Clinical & Translational Immunology|December 5, 2019
Translation of peptidoglycan metabolites into immunotherapeuticsMatthew E Griffin, Charles W Hespen, Yen-Chih Wang, et al.Applied and Environmental Microbiology|July 7, 2021
RecT Recombinase Expression Enables Efficient Gene Editing in Enterococcus sppVictor Chen, Matthew E Griffin, Pascal Maguin, et al.ACS Chemical Biology|February 9, 2019
Peptidoglycan Metabolite Photoaffinity Reporters Reveal Direct Binding to Intracellular Pattern Recognition Receptors and Arf GTPasesYen-Chih Wang, Nathan P Westcott, Matthew E Griffin, et al.Nature Chemical Biology|May 29, 2023
Chemoproteomics reveals microbiota-derived aromatic monoamine agonists for GPRC5AXiaohui Zhao, Kathryn R Stein, Victor Chen, et al.Science (New York, N.Y.)|August 27, 2021
Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapyMatthew E Griffin, Juliel Espinosa, Jessica L Becker, et al.Pageof 14